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Bacterial strainsAbstract In addition to lupeyl steryl ether (1) and 3-oxo-11a-hydroxyl-20 (29) lupen (2), a new
lupeol-3-isovanniloyl ester (3) was isolated from Paullinia pinnata. Using detailed 1D and 2D
NMR spectra and comparison with the published data, the new compound was characterised as
3-O-isovanilloyl-3R,5R,8R,9R,10R,13R,14S,17S,18R,19R-lup-20(29)-en, for which the trivial name
Paullinoyl was proposed. Compound 3 demonstrated signiﬁcant antibacterial activity on the tested
strains (MIC 15.2–30.20 lg/ml). The antibacterial activities obtained in this study conﬁrmed the use
of P. pinnata in traditional medicine for treating bacterial infections.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Paullinia pinnata Linn (Sapindaceae) is an African endemic
woody vine that inhabits the tropical rainforest zones of West
Africa, stretching fromNigeria to Cameroon. Sapindaceae con-
sists of about 136 genera and nearly 2000 species (Ferruci, 2000;
Prance, 2001). Paullinia consists of 180 species, located inNeotropical zones, except P. pinnata which is found also in
the African tropics (Hennmann, 1982). Its morphology is docu-
mented (Fransworth and Morris, 1976). Aqueous decoctions
and powdered root from P. pinnata are used in Nigeria, Togo
and Ghana traditional medicine for treating sores, wounds,
snake bites and other diseases such as erectile dysfunction,
malaria, dysentery, menstrual pain and coughs (Irvine, 1991;
Taylor et al., 1995; Zanble et al., 2006; Jimoh et al., 2007). P.
pinnata is called ogbe-okuje by the Yoruba natives of South-
WesternNigeria, meaning instant wound healer (oral communi-
cation). Previous phytochemical studies on P. pinnata resulted
in the isolation of alkaloid (Martins, 1877), triterpene saponins
(Bowden, 1962), ﬂavone glycoside (Abouraseed et al., 1999),
triterpenes and steroids (Miemanang et al., 2006). Recently,
5a-portiferastane-3b,6a-diol and 2-(4-hydroxyl-3,5-dimethoxyl
118 A.A. Lasisi et al.phenyl)-3-hydroxymethyl-2,3-dihydro-1,4,5-trioxaphenanthrene-
6-one were isolated from the leaf EtOAc extract of P. pinnata
(Dongo et al., 2009). Pharmacological study on aqueous
extracts from P. pinnata was conducted by a Togolese group
(Annanil et al., 2000). The strong antibacterial activity exhibited
by P. pinnata, in addition to the search for antibacterial phyto-
chemicals from natural sources, justiﬁed further attempts to
identify and isolate active compounds from P. pinnata. Details
of isolation, structural and antibacterial evaluation of isolated
compounds are described. To our knowledge, compounds 1, 2
and 3 are reported for the ﬁrst time from Paullinia.2. Experimental
2.1. General
Melting points, uncorrected were determined on the
Gallenkamp (Phillip Harris, England) apparatus. Unless
otherwise speciﬁed, UV spectra were taken in EtOH, re-
corded with a Perkin–Elmer Lambda 2 UV/VIS spectropho-
tometer. IR spectra were recorded on a Perkin Elmer FT-IR
spectrophotometer using KBr pellets. The GC–MS was per-
formed with a Hewlett Packard model 5890 Gas chromatog-
raphy coupled to an EI (70 eV) mass spectrometer, Hewlett–
Packard model 5971. Initial and ﬁnal temps were 70 C and
310 C, respectively (rate of heating 60 C/min) with He car-
rier gas. 1H and 13C NMR spectral data were recorded on a
Jeol spectrometer (200 MHz for 1H and 100 MHz for 13C
NMR in CDCl3) using TMS as internal reference. Column
chromatography was performed on silica gel [60, 70–230
mesh, ASTM (Merck, Darmstadt, Germany)]. TLC was
performed on precoated aluminium sheets [silica gel 60
PF254+360, 0.25 mm (Merck)], detected under UV light
(254 and 360 nm).
2.2. Plant material
The roots of P. pinnata, Linn (Sapindaceae) were collected at
the premises of Forest Research Institute of Nigeria (FRIN),
Jericho, Ibadan, Oyo State, Nigeria. The plant material was
collected and authenticated in July, 2008 by Mr. Felix Inyang
– a forester in the herbarium section of FRIN. A voucher spec-
imen was compared with authentic sample in FRIN, labelled
FHI 10572.
2.3. Extraction and isolation
Air-dried roots (1.3 kg) from P. pinnata were extensively and
exhaustively extracted with MeOH (10 L) to give a gummy
red solid (400 g) after the evaporation of the solvent. The gum-
my red solid was suspended in water, extracted with n-hexane
and CHCl3 in succession. CHCl3 extract was evaporated in va-
cuo, at reduced pressure to yield brown gummy solid (8 g).
Five grams of CHCl3 extract was chromatographed on a col-
umn of silica gel (350 g), eluting with increasing percentages
of n-hexane (66–68 C) in diethyl ether (Et2O). Fifty ﬁve frac-
tions (Frs) collected were grouped into four according to their
TLC proﬁle: Frs 1–15 (hexane), Frs 16–29 (hexane–Et2O, 8:1),
Frs 30–45 (hexane–Et2O, 1:1) and Frs 46–55 (hexane–Et2O,
1:3). Frs 16–29 afforded compound 1 (200 mg), Frs 30–44 fur-nished compound 2 (180 mg), Frs 45–50 yielded compound 3
(120 mg).
2.3.1. Lupeyl steryl ether (1)
Elution of the column with n-hexane–Et2O (8:1) yielded a
white gum, mp 220–222 C; TLC: Rf = 0.50 (hexane:EtOAc,
3:1 vol/vol); 1H NMR (200 MHz, CDCl3, d ppm): 4.80 (1H,
d, J= 2 Hz, H-29b), 4.65 (1H, dd, J= 8, 2 Hz, H-29a), 4.15
(2H, dd, J= 5 Hz, 10.8 Hz, H-10a,b), 3.61 (2H, t, J= 2 Hz,
H-1a,b), 3.18 (1H, dd, J= 11, 5.5 Hz, H-3), 2.36 (m, H-19),
1.67 (br, s, H-30), 1.25 (br, s, –(CH2)n –), 1.02, 0.96, 0.94,
0.82, 0.78, 0.75 (each 3H, s, H-23, 24, 25, 26, 27, 28); 13C
NMR (CDCl3, 100 MHz, d ppm): 151.2 (C-20), 109.6 (C-29),
78.6 (C-3), 63.4 (C-10), 55.5 (C-5), 50.5 (C-9), 48.4 (C-18),
48.1 (C-19), 37.4 (C-8), 43.0 (C-17), 42.9 (C-14), 41.7 (C-8),
39.9 (C-22), 38.5 (C-4), 38.3 (C-1), 37.5 (C-13), 37.2 (C-10),
35.5 (C-16), 34.6 (C-7), 33.1 (C-20), 32.1 (C-160), 29.8 (C-21),
29.5–29.9 (C-30-150), 28.1 (C-23), 28.0 (C-15), 27.4 (C-2), 25.2
(C-12), 22.8 (C-170), 21.0 (C-11), 19.4 (C-30), 18.3 (C-6), 18.1
(C-28), 16.5 (C-26), 16.0 (C-25), 15.4 (C-24), 14.5 (C-27),
14.5 (C-180).
2.3.2. 3-Oxo-11a-hydroxyl-20 (29) lupen (2)
Elution of column with n-hexane–Et2O (1:1) afforded a yellow
powder, mp 245–245 C; TLC: Rf = 0.40 (hexane:EtOAc, 3:1
vol/vol); 1H NMR (200 MHz, CDCl3, d ppm): 4.7 (1H, d,
J= 2 Hz, H-29b), 4.5 (1H, dd, J= 8, 2 Hz, H-29a), 3.75
(1H, m, H-11), 2.30 (1H, m, H-13), 1.76 (1H, m, H-13), 1.45
(1H, d J= 3.9, H-5), 1.41(1H, t, J= 7.8, H-9), 1.34 (1H,
dd, J= 10.9, 4.8) 1.67, 1.05, 1.04, 1.02, 0.98, 0.96, 0.79 (each
3H, s, H-30, 28, 26, 25, 23, 27, 24); 13C NMR (CDCl3,
100 MHz, d ppm): 212.2 (C-3), 148.3 (C-20), 109.9 (C-29),
70.4 (C-11), 54.9 (C-9), 54.6 (C-5), 47.8 (C-18), 47.7 (C-19),
47.6 (C-4), 43.0 (C-8), 42.4 (C-14), 42.3 (C-17), 42.1(C-1),
39.7 (C-22), 37.9 (C-10), 37.3 (C-15), 37.2 (C-13), 35.4 (C-7),
34.1 (C-2), 34.0 (C-16), 29.5 (C-21), 27.3 (C-12), 27.1 (C-23),
20.5 (C-24), 19.5 (C-6), 19.3 (C-30), 18.1 (C-28), 16.8 (C-26),
16.7 (C-25), 14.2 (C-27).
2.3.3. 3-O-Isovanilloyl-lup-20 (29)-en [(Paullinoyl, (3)]
Elution of the column with hexane–Et2O (1:1) furnished light-
yellow powder; mp 245–246 C; IR: KBr, mmax (cm1)]: 3350
[O–H, broad], 3090 [vinylic (‚C–H) stretch], 3050 [C–H
stretch, arene], 1645 [C‚O stretch], 1580 [C‚C stretch],
1402 cm1 [ C–O–H stretch].
HR-EI-MS m/z (rel int, %): 576.102 [(M+), 5%], 546
[(M+CO2, 3%], 452 [(M+CO2–C7H7O2), 10%], 248 [3%],
[395, 10%], [248, 3%], [207.3, 5%], [189, 100%], [123.1, 60%],
[147.3, 2%], [119, 51%], [1076, 3%], [82, 38%]. 1H and 13C
NMR (CDCl3): see Table 1.
2.3.4. Acid hydrolysis of compound 3
Compound 3 (20 mg) was reﬂuxed for 75 min with 4.0 M HCl
in MeOH (35 ml). The acid hydrolysate was concentrated, ex-
tracted with EtOH and examined by TLC on silica gel in
CHCl3/EtOAC (3:1).
1H NMR of the liberated triterpene moi-
ety was compared with naturally-occurring triterpene and
found to be similar. The acidic mother liquor was neutralised
with Na2CO3, ﬁltered, extracted with CH2Cl2 and evaporated
to dryness for the examination of the isovanillic acid moiety;
which proved to be isovanillic acid by direct comparison of
Table 1 1H, 13C NMR and HMBC connectivities for compound 3.
C HMQC HMBC DEPT 1H-1H
dC dH COSY NOESY
10 114.5 – H-50 C
20 112.0 7.40 d (1.9) H-60 CH 60
30 151.4 – H-20, H-50 C
40 146.5 – H-20, H-60OCH3 C
50 114.3 6.90 d (8.3) H-60 CH 50
60 124.3 7.50 dd (8.3, 1.9) H-20 CH 60
70 165.7 – H-20, H-3, H-1, H-2 C
–OCH3 56.3 3.98 br, s H-50, H-60 CH3
–OH – 6.1 br, s – CH3
1 38.8 1.52 ddd (13.5, 13.5, 3.7), H-1a 2H-2, H-9, 3H-25 CH2 2H-2
1.24 d (13.5), H-1b
2 24.1 1.99 m, H-2a H-3 CH2 2H-1, H-3
1.86 m, H-2b
3 77.9 5.36 dd (12.4, 3.9) 3H-23, 3H-24 CH 2H-2 H-5, 3H-23
4 37.9 – 2H-6, 3H-23, 3H-24 C
5 56.1 1.39 dd (12.6, 3.9) H-1, 3H-23 or 3H-25 CH 2H-6
6 18.2 1.52 m, H-6a H-5 CH2 H-5, 2H-7
1.27 m, H-6b
7 35.5 1.47 m, H-7b 3H-26 CH2
1.75 m, H-7a
8 41.7 – 2H-6, 3H-26, 3H-27 C
9 49.2 1.44 t (7.8) 2H-11, H-12, H-22 CH 2H-11
10 37.9 – H-5, 2H-6, H-9, 3H-25 C
11 22.1 1.52 m, H-11a H-9, H-12 CH2
1.27 m, H-11b
12 25.3 1.24 m, H-12b H-18 CH2 2H-11 H-18
1.49 m, H-12a
13 37.9 2.65 m 3H-27 CH H-18
14 43.2 – 2H-16, 3H-27 C
15 27.6 1.49 m, H-15b 3H-27 CH2 2H-16
1.24 m, H-15a
16 35.5 1.49 m, H-16b 3H-28 CH2 2H-15 3H-27
1.29 m, H-16a
17 43.2 – 2H-16 C
18 48.1 2.20 dd (10.94.8) H-16, 3H-28 CH H-13, H-19
19 46.9 2.16 ddd (10.9, 10.9, 4.8) 2H-29, 3H-30 CH H-18
20 150.2 – 3H-30 C
21 30.0 1.62 m (H-21b) 2H-22 CH2 2H-22
1.38 m (H-21a)
22 39.9 1.55 m (H-22b) 2H-16, 3H-28 CH2 2H-21
1.30 m (H-22a)
23 27.6 0.79 s CH3 H-1
24 14.7 0.84 s H-5 CH3 H-2
25 16.3 1.09 s H-5 or H-9 CH3 H-11
26 17.8 0.86 s H-9 CH3 H-11
27 14.7 1.22 s CH3 H-7, H-16
28 18.1 1.25 s 2H-22 CH3 2H-22
29 109.8 4.81 dd (8.3, 1.8) 3H-30 CH2
4.63 d (1.8)
30 19.6 1.71 s 2H-29 CH3
1H and 13C NMR spectra were acquired in CDCl3 at 200 MHz. Chemical shifts values are shown in the d scale (ppm), with coupling constants
(J, Hz) in parentheses, s = singlet, d = doublet, dd = doublet of doublet, m = multiplet.
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(Merck).
2.4. Antibacterial assay
The cultures of bacterial strains used were of the National
Collection for Industrial bacteria (NCIB) and some locallyisolated organisms (LIO). They were obtained at the Univer-
sity College Hospital (UCH), Ibadan, Oyo State, Nigeria.
The bacterial strains consist of Escherichia coli (NCIB,
15520), Bacillus subtilis (NCIB 85650), Staphylococcus aureus
(NCIB, 22350), Pseudomonas aeriginosa (NCIB, 27850), Shi-
gella dysenteriae (NCIB, 2350), Clostridium sporogenes (LIO)
and anaerobic Clostridium tetani (LIO).
120 A.A. Lasisi et al.2.4.1. Determination of minimum inhibitory concentrations
(MIC)
TheMIC of isolated compounds were evaluated using the broth
dilution assay (Ieven et al., 1979;Kudi et al., 1999). Varying con-
centrations (100 mg/ml, 50 mg/ml, 25 mg/ml, 15 mg/ml) of iso-
lated compounds were prepared. Each concentration (0.1 ml)
was added to 9 ml nutrient broth; in a 0.1 ml standardised test
organism of bacterial cells. The tubes were incubated at 37 C
for 24 h. Positive controls were set up, using DMSO and test
organisms without extracts. The tube with the least concentra-
tion of extract without growth after incubation was taken and
recorded as the minimum inhibitory concentration.
2.4.2. Statistical analysis
All data were expressed as mean ± SEM. Data were subjected
to two-way ANOVA followed by Student0s t-test, using Micro-
soft Excel* and Statistical* computer software packages. Dif-
ference in mean was considered signiﬁcant when p 6 0.05.
3. Results and discussion
The root chloroform extract from P. pinnata was submitted to
repeated column chromatography and monitored by TLC to
afford lupeol steryl ether (1), 3-oxo-11a-hydroxyl-20 (29)











































Figure 1 Structure of co1H and13C NMR of compounds, 1 and 2 were consistent with
those reported in the literature (Babady-Byla and Werner,
1996; Josinete et al., 2000).
Compound 3 was isolated as a light-yellow powder from
hexane–Et2O (1:4), recrystallised from hexane–EtOAc (7:10),
mp 245–246 C. Compound 3 tested positive to ferric chloride
solution, indicating its phenolic nature. IR spectrum shows
characteristic bands (mmax, cm
1) at 3350, attributable to phe-
nolic hydroxyl group; 1645, suggestive of conjugated carbonyl
groups; 1600, indicative of aromatic C‚C double bonds; 1402,
for C–O–H stretch and 1050, for C–O stretch of ether. The UV
spectrum of 1 displayed two maximum bands at 293 and
273 nm.
High Resolution Electron Impact Mass Spectrum (HR-EI-
MS) of 3 exhibited molecular ion [M+] peak at m/z 576.102,
corresponding to the molecular formula C38H56O4. The
1H
NMR spectrum of 3 displayed signals of seven tertiary methyl
groups and a doublet of doublet at d 5.63 (J= 12.4, 3.9) char-
acteristic of axial H-3 of a triterpene under an ester function; in
this case that of an isovanniloyl (Ahmadu and Attah-ur-
Rahman, 1994). A singlet at d 3.98 (3H, br) was assigned to aro-
matic group on C-40 position through HMBC and NOE
difference spectroscopy. The signals at d 4.59 [1H, d,
J= 1.8 Hz, H-29a] and d 4.71 [1H, dd, J= 8.3, 1.8 Hz,
H-29b] are ascribable to the vinylic protons on the side chainCH 3
CH 3
CH 3H3C

































mpounds 1, 2 and 3.
Table 2 Minimum inhibitory concentrations (MIC) of isolated compounds and reference antibacterial drug (gentamicin).
Minimum inhibitory concentration [MIC, (lg/ml)]
Isolated compounds S. aureus B. subtilis C. sporogenes E. coli P. aueriginosa S. dysenteriae Clostridium tetani
1 24.3 ± 2.5 22.3 ± 4.6 NA 37.2 ± 1.8 33.4 ± 1.7 15.4 ± 1.3 18.4 ± 0.6
2 28.2 ± 2.5 35.2 ± 8.2 NA 40.1 ± 5.5 37.4 ± 1.5 15.6 ± 0.8 25.2 ± 1.7
3 15.2 ± 5.5 21.1 ± 15.2 25.5 ± 1.5 30.2 ± 12.5 15.4 ± 11.3 20.0 ± 1.2 15.5 ± 5.5
Gentamicin 14.6 ± 10.3 15.1 ± 1.1 20.6 ± 2.4 27.1 ± 5.5 14.2 ± 7.2 12.1 ± 7.5 20.7 ± 1.5
DMSO NA NA NA NA NA NA NA
Key: NA= no activity.
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an AMX spin system at d 7.50 [1H, dd, J= 8.3, 1.9 Hz, H-60], d
7.40 [1H, d, J= 1.9 Hz, H-20] and d 6.90 [1H, d, J= 8.4 Hz, H-
50] were ascribable to the presence of additional isovanniloyl
moiety. 1H NMR spectrum of 3 exhibited one-proton, broad
singlet at d 6.10 (which lost on deuteration), assignable to phe-
nolic-OH. The broad band decoupled 13C NMR and DEPT
spectra of 3 exhibited 38 carbons, comprising 10 quaternary,
11 methylene, 9 methine, 8 methyl and a methoxyl carbon at
d 56.3 (br, s) (Table 1). A signal appearing at a conspicuously
low ﬁeld (d 109.8, C-29) was assigned to vinylic carbon on
the triterpene moiety (Ahmadu and Attah-ur-Rahman, 1994).
The signals for three methine carbons at d 112.0, 114.5 and
124.3 ppm were assigned to the methine carbons on the isovan-
niloyl moiety (Table 1). The unequivocal NMR assignments of
compound 3 (Table 1) were established by analyses from
COSY, HMQC, HMBC and NOESY experiments. The
HMBC spectrum of 3 conﬁrmed the correlation between meth-
oxyl protons at d 3.98 and carbon signal at d 146.5 (C-40). A
correlation was observed in the COSY spectrum of 3 justifying
methoxyl at C-40 position (Fig. 1). The position of vanilloyl es-
ter linkage at C-3 was conﬁrmed by HMBC spectrum, where
cross peaks between H-20/C-3 were observed. Furthermore,
the 1H–1H scalar correlation observed from the COSY analysis
revealed correlations between the methylene groups at d 1.99
and 1.86 [2H, H-2] with methine proton at d 5.36 [1H, H-3];
which shows a long-range coupling with methine hydrogen at
d 1.39 [1H, H-5]. A pair of methylene signals (2H, H-1 and
2H, H-2) showed distinct correlations with the quaternary oxy-
genated carbon at d 84.7 [C-3]. The relative stereochemistry of
compound 3 at C-3 was assigned for axial orientation on the
basis of J value and comparison of chemical shift pattern of
carbinyl proton (C-3–H) of related lupane triterpene (Ahmadu
and Attah-ur-Rahman, 1994; Kobayashi, 1997). The absolute
stereochemistry of compound 3 was assigned by Optical Rota-
tory Dispersion (ORD) spectrum. This was established by com-
paring the ORD spectrum of 3 with known lupane triterpene at
the same concentration (0.2 mg/ml) in MeOH (Chen et al.,
1983; Li et al., 1998). On the basis of this comparison, the abso-
lute stereochemistry of ten asymmetric centres in 3 are deter-
mined to be 3R,5R,8R,9R,10R,13R,14S,17S,18R,19R;
consistent with the conventional biosynthetic pathway of lu-
pane triterpenoids (Kobayashi, 1998). The structure of com-
pound 3 was established as 3-O-isovanniloyl-3R,5R,8R,9R,
10R,13R,14S,17S,18R,19R-lup-20(29)-en.
Compounds 1, 2 and 3 were evaluated for antibacterial
activities against selected Gram-positive and Gram-negative
bacteria, as well as anaerobic Clostridium spp. usually impli-
cated for sores and wounds (Birkhauser and Basel, 1978).Compound 3 exhibited signiﬁcant inhibition on the tested
pathogenic strains with MIC values between 15.2 and
30.2 lg/ml especially on C. tetani (MIC 15.5 lg/ml). The result
of MIC (Table 2) suggests that compounds 1–3 could possibly
act as a bactericidal agent to these organisms. Gram-positive
bacteria are common pathogens responsible for certain dis-
eased conditions; this includes S. aureus and E. coli for skin
infections (Damstatd and Lane, 1994; Trilla and Miro, 1995;
Noble, 1998) and C. tetani, implicated for sores and wounds
(Birkhauser and Basel, 1978; Park and Chun, 2001). From
these results, a kind of structure–activity relationship can be
drawn to some degree of conﬁdence. Earlier pharmacological
reports had attributed phenolic constituents as a criterion for
assessing the probable biological effects of the extracts of P.
pinnata (Zanble et al., 2006). Hydroxyl moiety is a reactive
group which hydrogen bond with the active sites of enzymes.
Pentacyclic triterpenes isolated from natural sources have been
reported as compounds with good medicinal properties (Park
and Chun, 2001, Jiri, 2003, Ca´ssia et al., 2010). Results of anti-
bacterial activities in this study validated the use of root decoc-
tions from P. pinnata in traditional medicine for treating sores,
wounds and other bacterial infections.
4. Conclusion
This research study reports a new lupeol-3-isovanilloyl ester (3)
fromP. pinnata. The new compoundwas fully characterised and
it is one of the rare reported phytochemicals inP. pinnata. Com-
pound 3 and other isolates from P. pinnata were evaluated for
their antibacterial activities on selected bacteria. Compound 3
demonstrated good in vitro antibacterial activities on C. tetani,
implicated for sores and wounds. Results obtained in this study
supported the use of root decoctions from P. pinnata in tradi-
tional medicine for treating bacterial infections.Acknowledgements
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